# Purchase Order #75N98026P01744

NIMH Assay Service Contract with Alamar Biosciences for Inflammation Panel

**Buyer:** National Institutes of Health

**Award Amount:** $40,000.00
**Ceiling:** $40,000.00

**Awarded:** September 21, 2026
**Period of Performance:** Sep 21, 2026 - Sep 20, 2027

**Identifier:** 75N98026P01744
**NAICS:** 541380

This contract award represents a purchase order agreement between the National Institute of Mental Health (NIMH) and Alamar Biosciences, Inc., a biotechnology company specializing in advanced biological assay services. The contract secures the provision of the NULISASEQ Inflammation Panel Assay Service, a specialized diagnostic service aimed at analyzing inflammation markers. This service is critical for supporting mental health research by providing detailed inflammatory profiling, which can contribute to understanding and treating mental health disorders. The scope includes delivery of the assay services as specified, with work to be performed in Fremont, California, over a one-year period. The contract was competitively awarded and involves a modest funding commitment, reflecting a targeted, specialized procurement. No information on subcontractors or prior related contracts is reported, nor was a contract vehicle or acquisition program specified. This award enhances NIMH's research capabilities through reliable assay services to support ongoing investigations into inflammation and mental health.

### Description

NIMH: SERVICE: NULISASEQ INFLAMMATION PANEL ASSAY SERVICE: SEVERABLE

[View original record](https://www.usaspending.gov/award/CONT_AWD_75N98026P01744_7529_-NONE-_-NONE-)